Thus, in this article, we analyzed the DNA methylation distribution and variation in genome-wide and mRNA transcription profiles in CD4+ T cells from proliferative LN patients and SLE patients without kidney injury compared to healthy controls to identify potential biomarkers for LN. This evidence concerns the gene CD4 and lobular neoplasia.